Agreement aims to enhance Pillar's PiVAT® bioinformatics platform with downstream reporting capabilities. NATICK, Mass., Jan. 7, 2025 /PRNewswire/ -- Pillar…
New claims-sourced RADAR models demonstrate positive predictive value BOSTON, Jan. 7, 2025 /PRNewswire/ -- Together Senior Health (Together), a Linus Health…
STOCKHOLM, Jan. 7, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) today announces that the Polish company Medim has placed an…
Oncology Quality Hub Recognized for MIPS Clinical Data Reporting NASHVILLE, Tenn., Jan. 7, 2025 /PRNewswire/ -- OneOncology, the physician-led platform…
Coeptis Secures Five New Clients With Total Contract Value of $1.7 Million Dollars With More On The Horizon Signaling AI-Driven…
Verismo will receive up to $4.05 million USD in investments from the Institute for Follicular Lymphoma Innovation (IFLI).The partnership with…
Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription…
MIAMI, FL / ACCESSWIRE / January 7, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir"), an emerging leader in age-reversal science…
GAITHERSBURG, Md., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development…
Over 300 Participants Have Completed Cumulative Six Months of Cytisinicline Treatment in the ORCA-OL Trial, Completing the Long-Term Exposure Requirement…